This inventor holds 7 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 8 EPO patents. Top assignees: Evalve, Inc., Auris Health, Inc., Vytronus, Inc.. Active years: 2009-2024.
Location History:
- Redwood City, CA (US) (2009 - 2013)
- Emerald Hills, CA (US) (2019 - 2022)
- Palo Alto, CA (US) (2022)
Company Filing History:
5 out of 141 
1 out of 471 
1 out of 23 Years Active: 2009-2024
Title: John P. Madden: Innovator in Cardiac Valve Technology
Introduction
John P. Madden is a prominent inventor based in Palo Alto, CA, known for his significant contributions to medical technology. He holds a total of 7 patents, focusing primarily on methods and devices that enhance cardiac valve treatment. His work has been instrumental in advancing techniques for tissue grasping and assessment, particularly in the context of cardiac valve regurgitation.
Latest Patents
Among his latest innovations, John P. Madden has developed methods and devices for tissue grasping and assessment. These devices, systems, and methods are designed to stabilize and grasp tissues such as valve leaflets. They assess the grasp of these tissues, approximate and fixate them, and evaluate the fixation to treat cardiac valve regurgitation, especially mitral valve regurgitation. This innovative approach has the potential to significantly improve patient outcomes in cardiac procedures.
Career Highlights
Throughout his career, John has worked with notable companies in the medical field, including Evalve, Inc. and Vytronus, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in cardiac technology.
Collaborations
John P. Madden has collaborated with several professionals in his field, including Eric A. Goldfarb and Jaime Eduardo Sarabia. These collaborations have fostered an environment of innovation and have led to the development of effective solutions in cardiac care.
Conclusion
John P. Madden's work in the field of cardiac valve technology exemplifies the impact of innovation on healthcare. His patents and collaborations continue to pave the way for advancements that improve the treatment of cardiac conditions.